Disclaimer:
For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
 
Overview:
AOD-9604 (Anti-Obesity Drug fragment 9604) is a synthetic C-terminal fragment of human growth hormone (HGH 177–191) studied for its lipolytic and metabolic regulatory properties. Unlike full-length HGH, AOD-9604 retains fat-burning activity without affecting growth or blood sugar levels, making it a key peptide of interest in obesity, metabolism, and tissue-repair research.
Mechanism of Action:
AOD-9604 exerts its effects through the beta-adrenergic receptor pathway, stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat formation). It does not bind to the growth hormone receptor, eliminating anabolic or diabetogenic side effects typically associated with HGH. Research suggests it enhances the breakdown of stored fat, improves metabolic rate, and supports recovery from soft tissue injury through localized action on adipose and connective tissue.
Research Highlights:
Demonstrated increased fat metabolism and reduction in adipose tissue in preclinical studies.
Shown to enhance lipid oxidation without altering insulin sensitivity or glucose levels.
Studied for potential applications in obesity management, cartilage repair, and joint recovery.
Non-anabolic profile makes it a safe research model for exploring targeted fat metabolism.
Specifications:
Form: Lyophilized powder (research-grade)
Purity: ≥99% (HPLC-tested)
Storage: Store refrigerated (2–8 °C), protected from moisture and light.